4//SEC Filing
Ottinger Bradley 4
Accession 0000805928-22-000066
CIK 0000805928other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:11 PM ET
Size
9.3 KB
Accession
0000805928-22-000066
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Ottinger Bradley
General Counsel and CCO
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-06-01−15,500→ 15,500 total→ Common Stock (15,500 underlying) - Exercise/Conversion
Common Stock
2022-06-01+15,500→ 18,573 total - Tax Payment
Common Stock
2022-06-01−3,775→ 14,798 total
Footnotes (4)
- [F1]This reflects the number of restricted stock units that vested on June 1, 2022.
- [F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F4]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on June 1, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on June 1, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
Documents
Issuer
Axogen, Inc.
CIK 0000805928
Entity typeother
Related Parties
1- filerCIK 0001813381
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:11 PM ET
- Size
- 9.3 KB